is wegovy a glp-1 drug Ro Launches Wegovy® Pill Through Integration with Novo Nordisk Professor Receives Grant to Study

Once-weekly glucagon-like peptide-1 receptor agonist dulaglutide is non-inferior to once-daily liraglutide and superior to placebo in Japanese patients with type 2 diabetes: a 26-week randomized phase III study

Its affecting their revenue with a decline in bariatric surgeries. Hospitals are reimaging their weight-loss programs, Marmolejob said, and integrating medical and surgical programs and cross-training clinicians

[DOI] [PubMed] [Google Scholar] 122.Xie Y., Choi T., Al-Aly Z

Conclusion A new era for obesity treatment has commenced where pharmacotherapy with combinations of entero-pancreatic hormones approach the WL efficacy of bariatric surgery

doi: 10.1038/s41586-019-1471-1